Habikino, Japan

Toshimitsu Mozai

This inventor holds 1 USPTO granted patent. Top assignee: Fujimoto Pharmaceutical Corporation. Active years: 1982.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Toshimitsu Mozai. Retrieved from https://idiyas.com/inventor/toshimitsu-mozai

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1982

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Toshimitsu Mozai

Introduction

Toshimitsu Mozai is a notable inventor based in Habikino, Japan. He is recognized for his contributions to the field of pharmacology, particularly through his innovative methods in preparing pharmacologically active compounds. His work has significant implications for the development of medications.

Latest Patents

Mozai holds a patent for a "Method for preparing pharmacologically active cyanoguanidine derivative." This invention involves the preparation of cimetidine, a pharmacologically active cyanoguanidine derivative. The process includes reacting 4-methyl-5-hydroxymethylimidazole or a salt thereof with a 2-substituted-1-methyl pyridinium salt. The intermediate product is then reacted with N-cyano-N'-methyl-N'-(2-mercaptoethyl)-guanidine. Notably, these reactions are conducted at room temperature and atmospheric pressure, eliminating the need for intermediate isolation and column chromatography in the recovery of the final product.

Career Highlights

Mozai is associated with Fujimoto Pharmaceutical Corporation, where he applies his expertise in pharmacology. His innovative approach to drug preparation has contributed to advancements in the pharmaceutical industry. His patent reflects his commitment to improving the efficiency of drug synthesis.

Collaborations

Some of his notable coworkers include Michitaro Fujimoto and Takaichi Fukui. Their collaborative efforts have likely enhanced the research and development processes within their organization.

Conclusion

Toshimitsu Mozai's contributions to pharmacology through his innovative patent demonstrate his significant role in the field. His work continues to influence the development of effective medications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…